Chat with GenHealth to automate any coding or chart task.
Malignant Neoplasm of Temporal Lobe (C71.2)
Name of the Condition
- Malignant neoplasm of temporal lobe
- Primary brain cancer of the temporal lobe
Summary
Malignant neoplasm of the temporal lobe refers to cancerous growths originating in the temporal region of the brain. These tumors can disrupt cognitive, auditory, and memory functions due to their location and potential to invade or compress surrounding structures. The condition is classified under ICD-10-CM code C71.2 and encompasses various subtypes based on tumor characteristics.
Causes
The exact cause of malignant temporal lobe tumors is often unknown. Potential factors include genetic mutations, prior radiation exposure, and other unidentified environmental influences. Some cases may be linked to inherited genetic syndromes, though these are relatively rare.
Risk Factors
- Family history of brain tumors
- Genetic syndromes (e.g., neurofibromatosis, Li-Fraumeni syndrome)
- Previous exposure to ionizing radiation
- Increased age (more common in older adults)
- Certain immune system disorders
Symptoms
- Persistent headaches, often severe
- Seizures
- Cognitive or personality changes (e.g., memory issues, language difficulties)
- Nausea or vomiting
- Vision or speech difficulties
- Weakness or numbness in limbs
- Balance or coordination problems
- Auditory disturbances (e.g., hearing loss, tinnitus)
Diagnosis
Diagnosis typically involves a combination of neurological examination, imaging tests such as MRI or CT scans to visualize the tumor, and biopsy to confirm malignancy. Additional tests may include EEG to assess electrical activity in the brain.
Treatment Options
- Surgery: To remove as much of the tumor as possible while preserving surrounding tissue
- Radiation therapy: To target and destroy cancer cells
- Chemotherapy: Uses drugs to kill or slow the growth of cancer cells
- Targeted therapy: Addresses specific molecular characteristics of the tumor
- Clinical trials: May be an option for advanced or recurrent cases
Prognosis and Follow-Up
Prognosis depends on factors such as tumor grade, size, and response to treatment. Regular follow-up with imaging and neurological assessments is essential to monitor for recurrence or progression. Long-term care may involve rehabilitation for cognitive or functional impairments.
Complications
- Neurological deficits (e.g., memory loss, language impairment)
- Seizure disorders
- Increased intracranial pressure
- Cognitive decline
- Recurrence of the tumor
Lifestyle & Prevention
- Avoid known risk factors (e.g., unnecessary radiation exposure)
- Maintain overall brain health through balanced diet and regular exercise
- Protect the head from injury
- Follow recommended screening for high-risk individuals
When to Seek Professional Help
Seek immediate medical attention for severe or worsening symptoms, such as persistent headaches, seizures, sudden neurological changes, or signs of increased intracranial pressure (e.g., vomiting, confusion).
Tips for Medical Coders
When coding for C71.2, ensure documentation specifies the temporal lobe location and confirms malignancy. Verify that the diagnosis aligns with clinical findings and imaging results. Accurate coding requires clear documentation of the tumor's anatomical site and histological confirmation of malignancy.
C71.2 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.